Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Programs, Funding & Financing

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Officials Discuss Leadership, Donor Commitments, Eliminating Leprosy At Start Of WHO Western Pacific Region Committee Session

The WHO “must demonstrate strong leadership backed by impeccable technical competency, [Malaysian] Prime Minister Datuk Seri Najib Tun Razak said” at the opening ceremony of the 61st Session of the WHO Regional Committee for the Western Pacific Monday, Bernama reports. “I believe this important conference can provide the input for future global action against pandemics and other trans-boundary diseases affecting all countries and communities, especially developing countries,” he said.

World Bank, IMF Discuss Development Funds At Annual Meeting

The World Bank’s International Development Association (IDA) fund requires new resources from Western governments to adequately fight global poverty, World Bank President Robert Zoellick said on Saturday during the annual meetings of the bank and International Monetary Fund in Washington, D.C., the Guardian reports. The IDA “provides soft loans and grants to the 79 poorest countries,” the newspaper writes.

Financing HIV/AIDS Prevention, Treatment Could Cost $400B-$700B Over 20 Years

A new report published by the Results for Development Institute in the Lancet “has offered governments and donors a glimpse into the future of HIV epidemics – and what it will cost to prevent and treat them. Researchers warn of hard choices ahead and a need for some countries to take more responsibility for their national programmes, IRIN/PlusNews reports. Study authors present their “cheapest” and “ideal” scenarios for HIV funding in the future, according to IRIN/PlusNews.

Opinions: Learning To Live With Malaria; U.S. Food Aid Policy; Foreign Aid Reform

Adapting To Malaria, Rather Than Eradicating It, Might Lead To Significant Gains Recent “discoveries of a possible wild reservoir for humankind’s most malignant malaria, some 130 years after the discovery of the malaria parasite, could mean that it will be impossible to eradicate malaria,” Sonia Shah, the author of “The Fever: How…

CQ HealthBeat Examines HIV Prevention Research Funding

The global economy has affected HIV/AIDS prevention research, so “scientists and those who fund them are struggling to set priorities among several competing research methods that could slow the spread of the disease, which causes about 2.7 million new infections worldwide a year,” CQ HealthBeat reports. The article looks at the “tension among those searching for effective vaccines and those who are concentrating on other prophylactic methods. With more and more lines of inquiry showing promise, scientists may be victims of their own success.”

U.S. ‘Among The Lowest’ In Aid Quality And Effectiveness, Report Finds

The U.S. “ranks among the lowest in terms of the quality and effectiveness of its aid,” according to a new Center for Global Development (CGD)/Brookings Institution report, Foreign Policy’s “The Cable” blog writes. The report examined “30 separate, measurable indicators and evaluated them in terms of four dimensions: maximizing efficiency (how smartly the money is distributed), fostering institutions (whether the money is helping host governments), reducing the burden on recipient countries (how much the host countries need to do to get the money), and transparency and learning (how much we know about how the aid is being spent).”

Donors Pledge Nearly $12B For Global Fund, Missing Lowest Funding Target

Donors at a replenishment meeting in New York on Tuesday pledged $11.7 billion over three years for the Global Fund to Fight AIDS, Tuberculosis and Malaria, “higher than past support but below the lowest target set by the agency in its efforts to combat disease in the developing world,” the Financial Times reports (Jack, 10/5).

Miller-McCune Examines Impact Of Limited Access To Schistosomiasis Drug In Africa

Miller-McCune examines the limited access populations living in Africa have to the schistosomiasis drug praziquantel – “the only commercially available treatment for the disease.” Schistosomiasis “kills about 300,000 people and afflicts more than 200 million yearly with chronic and severe anemia, abdominal pain, diarrhea, infertility and bladder cancer,” the magazine writes, adding that the disease is “[e]specially prevalent in sub-Saharan Africa, [where] by some estimates, nearly 800 million people are at risk of infection.”